Intratumoral gemcitabine levels
Showing 26 - 50 of >10,000
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck Trial in United States (Drug: SL-172154)
Terminated
- Cutaneous Squamous Cell Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Drug: SL-172154
-
Los Angeles, California
- +5 more
May 18, 2022
Metastatic Pancreatic Cancer Trial in Spain (OMO-103, Nab-Paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Cancer
- OMO-103
- +2 more
-
L´Hospitalet de Llobregat, Barcelona, Spain
- +3 more
Sep 22, 2023
Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 20, 2022
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Recurrent NSCLC, Stage IV NSCLC Trial in Detroit (docetaxel, pemetrexed disodium, gemcitabine HCl)
Terminated
- Recurrent Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
- docetaxel
- +3 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Sep 3, 2020
Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Metastatic
- Nab-paclitaxel
- +2 more
-
New York, New York
- +7 more
Jan 3, 2023
Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)
Recruiting
- Soft Tissue Sarcoma
- Gemcitabine
- +4 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 26, 2023
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine
Not yet recruiting
- Pancreatic Cancer Metastatic
- Pancreatic Adenocarcinoma Metastatic
- Botensilimab
- +3 more
-
Scottsdale, ArizonaClinical Trials Nurse Navigator
Oct 3, 2023
Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial
Recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- +5 more
- Durvalumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Diffuse Intrinsic Pontine Glioma Trial in Aurora (Gemcitabine)
Recruiting
- Diffuse Intrinsic Pontine Glioma
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 31, 2022
Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)
Not yet recruiting
- Pancreatic Cancer
- Metastatic Adenocarcinoma
- Nab paclitaxel
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Mar 8, 2023
Gastric Adenocarcinoma Trial in Pessac (Gastrectomy)
Recruiting
- Gastric Adenocarcinoma
- Gastrectomy
-
Pessac, FranceHôpital du Haut Lévêque
Mar 23, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)
Active, not recruiting
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- Lonsurf
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 29, 2022
Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,
Active, not recruiting
- Non-Squamous Non-Small Cell Lung Carcinoma
- +7 more
- Nivolumab
- +3 more
-
Abington, Pennsylvania
- +1 more
Sep 14, 2022
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Biopsy
- +4 more
-
Chicago, Illinois
- +11 more
Jun 28, 2022
Leiomyosarcoma, Adult Trial in France (Association of berzosertib with gemcitabine, Gemcitabine)
Recruiting
- Leiomyosarcoma, Adult
- Association of berzosertib with gemcitabine
- Gemcitabine
-
Bordeaux, France
- +5 more
Jul 27, 2022
Recurrent DLBCL, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory DLBCL Trial in United States (drug, other, biological)
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +5 more
- Atezolizumab
- +9 more
-
Duarte, California
- +3 more
Nov 17, 2022
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Malignant Tumor of Bone and Articular Cartilage, Malignant Tumors of Female Genital Organs, Malignant Tumors of Independent
Recruiting
- Malignant Neoplasm of Bone and Articular Cartilage
- +9 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Oct 26, 2022
Lymphoma, Solid Tumor Trial in Buffalo (Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)
Terminated
- Lymphoma
- Solid Neoplasm
- Gemcitabine Hydrochloride
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022